Antiandrogen withdrawal syndrome with cyproterone acetate

Keyphrases

• Cyproterone Acetate 100%
• Antiandrogen Withdrawal Syndrome 100%
• Prostate-specific Antigen Level 33%
• Androgen Ablation 33%
• Steroidal Antiandrogen 33%
• Disease Progression 16%
• Imaging Studies 16%
• Withholding 16%
• Time Response 16%
• Total Prostate-specific Antigen 16%
• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 16%
• Androgen-independent 16%
• Androgen Suppression 16%
• Concurrent Exposure 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Withdrawal Syndrome 100%
• Antiandrogen 100%
• Cyproterone Acetate 100%
• Androgen 66%
• Prostate Specific Antigen 33%
• Disease Exacerbation 16%
• Prostate Cancer 16%

Neuroscience

• Withdrawal Syndrome 100%
• Antiandrogen 100%
• Cyproterone Acetate 100%
• Androgen 66%
• Prostate Specific Antigen 33%